GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Resources
      • GM Myth Makers
      • Gene Editing
      • Non-GM successes
      • GM Quotes
      • GM Myths
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
      • GM Booklet
      • GM Book
    • Contact
    • About
    • Search
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
  • Resources
    • Non-GM Successes
    • GM Myth Makers
    • Gene Editing
    • GM Quotes
    • GM Myths
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
    • GM Booklet
    • GM Book
  • Donations
  • Contact
  • About
  • Search

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

GENE EDITING MYTHS, RISKS, & RESOURCES

Gene Editing Myths and Reality

US synbio firm Intrexon investigated for securities fraud

  • Print
  • Email
Details
Published: 17 September 2018
Twitter

Mosquito on sea of dollars

Share price falls for firm that owns GM mosquitoes, salmon, and apples

US synbio firm Intrexon, which owns GMO mosquitos, salmon and apples, is being investigated by lawyers for securities fraud.

The law firm Pomerantz LLP is investigating claims on behalf of investors of Intrexon Corporation. The investigation concerns whether Intrexon and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

On August 9, 2018, Intrexon announced that it would restate the unaudited interim consolidated financial statements included in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2018. Intrexon advised investors that the restatement was the result of incorrect application of certain aspects of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers. According to the company, "these errors have resulted in an overstatement of deferred revenue and accumulated deficit by approximately $67 million as of the adoption date."

On this news, Intrexon's share price fell $0.34 per share, or 2.21%, to close at $15.05 per share on August 10, 2018. Then, on August 13, 2018, Intrexon filed an amended and restated 10-Q for the quarter ended March 31, 2018. On this news, Intrexon's share price fell $0.95 per share, or 6.31%, to close at $14.10 per share on August 13, 2018.

Source: PR Newswire
https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-intrexon-corporation----xon-300713177.html

 

Menu

Home

Subscriptions

News Archive

News Reviews

GM Book

Resources

Non-GM Successes

GM Myth Makers

GM Myths

GM Quotes

GM Booklet

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2025 GMWatch.
Web Development By SCS Web Design